Akin Gump IP Lawyers Pen Law360 Article on Effect of New Testimonial Evidence on Inter Partes Reviews

June 5, 2018

Reading Time : 1 min

Contact:

Jacinta O'Shea-Ramdeholl

Director of Communications

Sarah Richmond

Senior Communications Manager

Law360 has published “How New Testimonial Evidence Affects IPR Institution,” an article written by Akin Gump intellectual property partner Rubén Muñoz and counsel Melissa Gibson and Matthew Hartman looking at the impact of inter partes review (IPR) proceedings involving patents in the biotechnology and chemical arts to assess the prevalence and value of new testimonial evidence (NTE).

The authors write that it has been nearly two years since a new rule took effect permitting patent owners to submit NTE in support of a preliminary response to an IPR petition. After analyzing more than 300 proceedings that have taken place during that time, the article reports that the submission of NTE did not reduce overall institution rates.

Muñoz, Gibson and Hartman offer several reasons to account for the overall lack of impact of NTE on institution rates. They also highlight factors for patent owners to consider when deciding whether or not to submit NTE with a preliminary response.

The article concludes by observing that patent owners “have not blindly embraced the use of NTE to support their preliminary responses.” Further, “the decision of whether or not to use NTE in support of a preliminary response involves consideration of multiple factors and may not necessarily be focused solely on preventing institution.” Instead, the authors say, it may involve “other overarching considerations such as the potential for early settlement.”

To read the full article, please click here.

Share This Insight

Related Services, Sectors, and Regions

© 2024 Akin Gump Strauss Hauer & Feld LLP. All rights reserved. Attorney advertising. This document is distributed for informational use only; it does not constitute legal advice and should not be used as such. Prior results do not guarantee a similar outcome. Akin is the practicing name of Akin Gump LLP, a New York limited liability partnership authorized and regulated by the Solicitors Regulation Authority under number 267321. A list of the partners is available for inspection at Eighth Floor, Ten Bishops Square, London E1 6EG. For more information about Akin Gump LLP, Akin Gump Strauss Hauer & Feld LLP and other associated entities under which the Akin Gump network operates worldwide, please see our Legal Notices page.